https://www.selleckchem.com/EGFR(HER).html
With these results, this work sets the basis for further development of novel 18F-labeled GSK-3β PET probes.This study describes the development of lipid nanoparticles (LNPs) for the efficient and selective delivery of plasmid DNA (pDNA) to the lungs. The GALA peptide was used as a ligand to target the lung endothelium and as an endosomal escape device. Transfection activity in the lungs was significantly improved when pDNA was encapsulated in double-coated LNPs. The inner coat was composed of dioleoylphsophoethanolamine and a stearylated octa
Like
Comment
Share
